Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-40
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

The investigators carried out a multi-center comparative study, involving hospitals including the Second Affiliated Hospital of Zhejiang University School of Medicine, Peking Union Medical College Hospital, West China Hospital, Wenzhou First Hospital, and Li Huili Hospital. This study aimed to compare the efficacy of medication and surgery for specific subtypes of microadenomas and clearly defined macroadenomas (Knosp grades 0-2), in order to determine which is more effective and which has fewer benefits, thereby enhancing the evidence base.

Eligibility criteria

Qualifiers

Prolactin level greater than three times the normal upper limit

MRI indicates Knosp Grade 0-2 pituitary adenoma

Disqualifiers

MRI indicates Knosp grade 3-4 pituitary adenoma

Taking antidepressants or other psychotropic drugs

Patients allergic to bromocriptine or cannot tolerate surgery

Women defined as surgical infertility (i.e. hysterectomy, bilateral salpingectomy, or bilateral oophorectomy), or amenorrhea for more than 2 years

Trial design

Treatments tested in this trial

  • Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
  • Bromocriptin 2.5mg, 2-3 times a day

Treatment groups

600 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead sponsor

Peking Union Medical College Hospital

Collaborator

West China Hospital

Collaborator

First Affiliated Hospital of Wenzhou Medical University

Collaborator

Ningbo Medical Center Lihuili Hospital

Collaborator